Myelofibrosis: Beyond Ruxolitinib
Other JAK inhibitors, combinations, and novel therapies offer more hope for patients
Source: medpagetoday.com
Stay updated with breaking news from James Rossetti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Other JAK inhibitors, combinations, and novel therapies offer more hope for patients
Increased interest follows mutation discoveries, development of targeted therapies
Genetics already informs prognosis, may help guide therapy development beyond JAK2 inhibition